The Role of Industry Associations in influencing Healthcare Innovations and Sustainable Development in India: Opportunities, Challenges, and Policy considerations
A stakeholder dialogue was organized by CRB together with the Open University, UK on 19th April 2017 in New Delhi. The aim of this dialogue was to initiate a discussion on the role of sectoral associations and other stakeholders for evolving a responsible pharmaceutical sector in India, especially given that a large population of the country don’t have adequate access to medicine – either due to their availability in the public health facilities or high costs. The government has resolved to improve affordability and accessibility of medicines especially for the marginalized section of our society. Given this background, the Sustainable Development Goals (SDGs) seem to provide an interesting foundation and framework for the pharmaceutical industry to pro-actively assess how they can contribute to some of the SDGs. A suggestion that was echoed by several participants (from across stakeholder groups) was the need for having a multi-stakeholder forum on responsible pharmaceuticals in India, and identify a road-map for meeting some of these expectations.